-
PDF
- Split View
-
Views
-
Cite
Cite
P433. Canadian patient and caregiver perspectives on subsequent entry biologics / biosimilars for inflammatory bowel disease, Journal of Crohn's and Colitis, Volume 10, Issue suppl_1, March 2016, Page S319, https://doi.org/10.1093/ecco-jcc/jjw019.552
Close -
Share
This content is only available as a PDF.
© 2016 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com
Issue Section:
Clinical: Therapy & observation
